Physician profile
Martha Leen
NPI 1093716458
$2,250.24
in general payments reported to CMS, 2019-2025
21 companies · $607 in 2025
The $607 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $201 · 2021: $71.02 · 2022: $157 · 2023: $463 · 2024: $507 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $595.04 | 2021-2025 | Clareon, Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol |
| Abbvie INC. | $380.40 | 2022-2025 | |
| Allergan, INC. | $206.24 | 2019-2020 | |
| Sight Sciences, INC. | $155.32 | 2024 | Omni Surgical System |
| Apellis Pharmaceuticals, INC. | $117.94 | 2023 | |
| Bausch & Lomb Americas INC. | $102.62 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.76 | 2019-2020 | |
| Thea Pharma INC. | $86.64 | 2023-2025 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $85.10 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $71.47 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $70.43 | 2019-2021 | |
| Biotissue Holdings INC. | $47.99 | 2023-2024 | |
| Harrow Eye, LLC | $42.34 | 2023-2025 | Iheezo |
| New World Medical,INC. | $41.69 | 2020-2025 | Via360, Streamline, Kahook Dual Blade |
| Carl Zeiss Meditec USA, INC. | $28.54 | 2025 | Cirrus Hd-Oct |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $27.50 | 2021 | |
| Kala Pharmaceuticals, INC. | $25.43 | 2019 | |
| Akorn, INC. | $20.51 | 2019 | |
| Rxsight INC | $20.42 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Mallinckrodt Enterprises LLC | $17.64 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Leen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.